Shah Rukh Khan, Ajay Devgn and Tiger Shroff respond to notices issued by Maharashtra’s Food and Drug Administration (FDA) over their roles in a Vimal Elaichi advertisement. According to the FDA commissioner, Tukaram Mundhe, the actors reply to the regulator’s notices, and requests for hearings are made and then concluded.
The FDA frames the issue as “surrogate advertising,” asserting that brand endorsers cannot avoid responsibility under food safety laws. The regulator indicates it is moving ahead with further action following the replies and the conclusion of the hearings.
The outlets report the same core sequence: FDA issues notices, the actors submit responses, and the FDA continues its process. Differences are limited to presentation details, with coverage focusing either on the actors’ participation in replying to the notices and seeking hearings, or on the FDA’s legal basis for treating the campaign as surrogate advertising.
